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Introduction and Aims: We have previously shown by culture that the lungs of
clinically stable Cystic Fibrosis (CF) patients are not only colonised by commonly
recognised aerobic bacteria, such as Pseudomonas aeruginosa, but also by a range
of potentially pathogenic anaerobic species. The aim of this study was to determine
whether anaerobes are also present in the sputum of CF patients with an acute
exacerbation of pulmonary infection.
Methods: Sputum and mouthwash samples were collected, prior to commencing
and at the end of antibiotic therapy, from 30 adult CF patients admitted for treatment
of an acute exacerbation of pulmonary infection. Bacteria within the samples were
detected by plating on selective agars, quantiﬁed by total viable count and identiﬁed
by PCR and sequencing of 16S ribosomal RNA genes.
Results: Anaerobes from a range of species including Prevotella, Veillonella,
Propionibacterium, Actinomyces and Gemella were detected in high numbers (up to
1×108 cfu/g of sputum) from all patients prior to commencing antibiotic treatment
with the predominant aerobes (P. aeruginosa or Burkholderia cepacia complex)
detected in similar or smaller numbers. Anaerobes were also detected in all patients
at the end of antibiotic treatment but in the majority of patients they were present
in lower numbers than detected before antibiotic treatment.
Conclusion: These results indicate that anaerobes are present within the CF lung
during an acute exacerbation of pulmonary infection. Their presence could be of
important clinical relevance to CF patients as they may contribute signiﬁcantly to
the inﬂammatory process.
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Introduction and Aims: We have shown by culture that the lungs of Cystic
Fibrosis (CF) patients are not only chronically infected with pathogens, such as
Pseudomonas aeruginosa, but also by an array of other bacterial species, many of
which are anaerobes [1]. As P. aeruginosa grows within a bioﬁlm in the lungs of
CF patients and as bioﬁlm formation is considered an important virulence factor
for CF pulmonary infection, this pilot study aimed to determine the ability of these
anaerobes to form bioﬁlms.
Methods: Bioﬁlm formation by the predominant anaerobic species (Prevotella,
Veillonella, Propionibacterium and Actinomyces) isolated from the sputum of
CF patients, was assessed using a crystal violet micro-titre tray assay [2].
Results: Initial investigations with selected strains from each genera, in which the
adhesion and bioﬁlm times were varied, revealed that an adhesion time of 4 hours
and a bioﬁlm growth time of 24 hours were the optimal conditions for bioﬁlm
formation.
Using these parameters, the majority of the 42 isolates tested demonstrated the
ability to form bioﬁlms with signiﬁcant biomass.
Conclusion: These results indicate that anaerobes present within the CF lung are
capable of bioﬁlm formation in vitro.
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Currently it is unknown if there are common infective factors related to the
presence of “shared” strains of Pseudomonas aeruginosa isolated from some
patients attending the same CF clinic. Here we report our study into a comparison
of bacterial binding to a pneumocyte cell line, A549 by “shared” and unique clinical
isolates and from immunocompromised non CF patients to explore the possibility
of differing afﬁnities in establishing lung infection.
Methods: Estimation of bacteria binding per cell was carried out following a 2 h
bacterial exposure to a conﬂuent layer of A549 cells as described by Simpson et al
Infect Immunol 1992:60;3771−9. Shared strains are deﬁned as isolates with same
genotype carried by two or more patients. Representative isolates from 14 shared
strains were used here and compared with 20 isolates with unique genotypes picked
at random and 15 isolates from non CF patients. Binding of bacteria was allocated
to one of three groups, no binding (<2 bacteria per cell), moderate binding (3−15
bacteria per cell) and high binding (>15 bacteria per cell).
Results: With the shared strains, 11 did not bind, 2 showed moderate binding
and 1 high binding. 10 of the unique strains gave no binding, 6 moderate binding
and 4 high binding. Despite these differences, Chi squared analysis indicated no
signiﬁcant difference between the two groups (p< 0.2). In the case of the non CF
isolate, one gave no binding, moderate binding was seen with 5 and 9 gave high
binding (p> 0.05).
Conclusions: There was no signiﬁcant difference between shared and unique
isolates in their afﬁnity for A549 cells indicating that factors for increased trans-
missibility lie elsewhere. These results also indicate a trend in CF isolates towards
low binding afﬁnity to A549 cells and thus possibly to lung epithelium.
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Infection by Pseudomonas aeruginosa plays an important role in the morbidity and
mortality associated with cystic ﬁbrosis (CF). In the Liverpool adult CF unit, it has
been shown that patients infected with the transmissible Liverpool epidemic strain
(LES) of P. aeruginosa suffer greater morbidity than those infected by non-LES
strains. In some LES isolates, an unusual hypervirulence (HV) phenotype, charac-
terized by over-expression of quorum-sensing (QS)-regulated virulence genes, has
been identiﬁed.
Using assays for the QS-regulated exoproducts pyocyanin and LasA, we have
demonstrated that the unusual HV phenotype is widespread amongst LES isolates.
Sequential isolates from six individual patients revealed a wide variation in ex-
oproduct secretion, antimicrobial susceptibility, morphology, motility, auxotrophy
and hypermutability. Some LES isolates secreted no pyocyanin or LasA, due
to mutations in the lasR gene. Isolates with the same colony morphology were
found to have very different phenotypic characteristics. In addition, LES isolates
exhibited variable virulence in a Caenorhabditis elegans infection model. These
studies suggest that the unusual HV phenotype may play an important role in the
greater morbidity of CF patients infected by the LES, and that LES isolates vary
greatly in virulence and several phenotypic characteristics, including antimicrobial
susceptibilities.
This work was undertaken under the framework of the UK CF Microbiology
Consortium, an initiative funded by the Big Lottery Fund in association with the
Cystic Fibrosis Trust.
